Evotec SE (OTCMKTS:EVTCY – Get Free Report) shares passed below its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $1.81 and traded as low as $1.5304. Evotec shares last traded at $1.57, with a volume of 94,415 shares changing hands.
Evotec Stock Down 2.5%
The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $505.24 million, a PE ratio of 3.73 and a beta of 0.98. The stock has a 50-day simple moving average of $1.81 and a 200-day simple moving average of $2.39.
Evotec Company Profile
Evotec SE is a Germany-based biotechnology company that provides drug discovery and development services to pharmaceutical, biotechnology and academic partners. The company combines scientific expertise, technology platforms and proprietary research programs to support the identification and advancement of potential medicines.
Its activities span early-stage research and development, including target identification and validation, assay development, screening, medicinal chemistry, computational drug design, pharmacology and preclinical development.
Further Reading
- Five stocks we like better than Evotec
- Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up
- Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
- Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next
- Why Wall Street Expects Even More From SanDisk After Its 575% Rally
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
